Report Detail
Global RNA Vaccines Market Insights, Forecast to 2025
- RnM3087597 |
- 11 June, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
RNA Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the RNA Vaccines market is segmented into
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Segment by Application, the RNA Vaccines market is segmented into
Infectious Disease
Cancer
Other
Regional and Country-level Analysis
The RNA Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the RNA Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and RNA Vaccines Market Share Analysis
RNA Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in RNA Vaccines business, the date to enter into the RNA Vaccines market, RNA Vaccines product introduction, recent developments, etc.
The major vendors covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 Study Coverage
- 1.1 RNA Vaccines Product Introduction
- 1.2 Market Segments
- 1.3 Key RNA Vaccines Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global RNA Vaccines Market Size Growth Rate by Type
- 1.4.2 Individualized Cancer Treatment MRNA Vaccine
- 1.4.3 Infectious Disease Treatment MRNA Vaccine
- 1.4.4 Infection Prevention MRNA Vaccine
- 1.5 Market by Application
- 1.5.1 Global RNA Vaccines Market Size Growth Rate by Application
- 1.5.2 Infectious Disease
- 1.5.3 Cancer
- 1.5.4 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): RNA Vaccines Industry Impact
- 1.6.1 How the Covid-19 is Affecting the RNA Vaccines Industry
- 1.6.1.1 RNA Vaccines Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and RNA Vaccines Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for RNA Vaccines Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the RNA Vaccines Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global RNA Vaccines Market Size Estimates and Forecasts
- 2.1.1 Global RNA Vaccines Revenue 2015-2026
- 2.1.2 Global RNA Vaccines Sales 2015-2026
- 2.2 RNA Vaccines Market Size by Region: 2020 Versus 2026
- 2.2.1 Global RNA Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global RNA Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global RNA Vaccines Competitor Landscape by Players
- 3.1 RNA Vaccines Sales by Manufacturers
- 3.1.1 RNA Vaccines Sales by Manufacturers (2015-2020)
- 3.1.2 RNA Vaccines Sales Market Share by Manufacturers (2015-2020)
- 3.2 RNA Vaccines Revenue by Manufacturers
- 3.2.1 RNA Vaccines Revenue by Manufacturers (2015-2020)
- 3.2.2 RNA Vaccines Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global RNA Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by RNA Vaccines Revenue in 2019
- 3.2.5 Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 RNA Vaccines Price by Manufacturers
- 3.4 RNA Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 RNA Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers RNA Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into RNA Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global RNA Vaccines Market Size by Type (2015-2020)
- 4.1.1 Global RNA Vaccines Sales by Type (2015-2020)
- 4.1.2 Global RNA Vaccines Revenue by Type (2015-2020)
- 4.1.3 RNA Vaccines Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global RNA Vaccines Market Size Forecast by Type (2021-2026)
- 4.2.1 Global RNA Vaccines Sales Forecast by Type (2021-2026)
- 4.2.2 Global RNA Vaccines Revenue Forecast by Type (2021-2026)
- 4.2.3 RNA Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global RNA Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global RNA Vaccines Market Size by Application (2015-2020)
- 5.1.1 Global RNA Vaccines Sales by Application (2015-2020)
- 5.1.2 Global RNA Vaccines Revenue by Application (2015-2020)
- 5.1.3 RNA Vaccines Price by Application (2015-2020)
- 5.2 RNA Vaccines Market Size Forecast by Application (2021-2026)
- 5.2.1 Global RNA Vaccines Sales Forecast by Application (2021-2026)
- 5.2.2 Global RNA Vaccines Revenue Forecast by Application (2021-2026)
- 5.2.3 Global RNA Vaccines Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America RNA Vaccines by Country
- 6.1.1 North America RNA Vaccines Sales by Country
- 6.1.2 North America RNA Vaccines Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America RNA Vaccines Market Facts & Figures by Type
- 6.3 North America RNA Vaccines Market Facts & Figures by Application
7 Europe
- 7.1 Europe RNA Vaccines by Country
- 7.1.1 Europe RNA Vaccines Sales by Country
- 7.1.2 Europe RNA Vaccines Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe RNA Vaccines Market Facts & Figures by Type
- 7.3 Europe RNA Vaccines Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific RNA Vaccines by Region
- 8.1.1 Asia Pacific RNA Vaccines Sales by Region
- 8.1.2 Asia Pacific RNA Vaccines Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific RNA Vaccines Market Facts & Figures by Type
- 8.3 Asia Pacific RNA Vaccines Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America RNA Vaccines by Country
- 9.1.1 Latin America RNA Vaccines Sales by Country
- 9.1.2 Latin America RNA Vaccines Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America RNA Vaccines Market Facts & Figures by Type
- 9.3 Central & South America RNA Vaccines Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa RNA Vaccines by Country
- 10.1.1 Middle East and Africa RNA Vaccines Sales by Country
- 10.1.2 Middle East and Africa RNA Vaccines Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa RNA Vaccines Market Facts & Figures by Type
- 10.3 Middle East and Africa RNA Vaccines Market Facts & Figures by Application
11 Company Profiles
- 11.1 Moderna Therapeutics
- 11.1.1 Moderna Therapeutics Corporation Information
- 11.1.2 Moderna Therapeutics Description, Business Overview and Total Revenue
- 11.1.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Moderna Therapeutics RNA Vaccines Products Offered
- 11.1.5 Moderna Therapeutics Recent Development
- 11.2 CureVac
- 11.2.1 CureVac Corporation Information
- 11.2.2 CureVac Description, Business Overview and Total Revenue
- 11.2.3 CureVac Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 CureVac RNA Vaccines Products Offered
- 11.2.5 CureVac Recent Development
- 11.3 Translate Bio
- 11.3.1 Translate Bio Corporation Information
- 11.3.2 Translate Bio Description, Business Overview and Total Revenue
- 11.3.3 Translate Bio Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Translate Bio RNA Vaccines Products Offered
- 11.3.5 Translate Bio Recent Development
- 11.4 BioNTech
- 11.4.1 BioNTech Corporation Information
- 11.4.2 BioNTech Description, Business Overview and Total Revenue
- 11.4.3 BioNTech Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 BioNTech RNA Vaccines Products Offered
- 11.4.5 BioNTech Recent Development
- 11.5 Sangamo Therapeutics
- 11.5.1 Sangamo Therapeutics Corporation Information
- 11.5.2 Sangamo Therapeutics Description, Business Overview and Total Revenue
- 11.5.3 Sangamo Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sangamo Therapeutics RNA Vaccines Products Offered
- 11.5.5 Sangamo Therapeutics Recent Development
- 11.6 Argos Therapeutics
- 11.6.1 Argos Therapeutics Corporation Information
- 11.6.2 Argos Therapeutics Description, Business Overview and Total Revenue
- 11.6.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Argos Therapeutics RNA Vaccines Products Offered
- 11.6.5 Argos Therapeutics Recent Development
- 11.7 In-Cell-Art
- 11.7.1 In-Cell-Art Corporation Information
- 11.7.2 In-Cell-Art Description, Business Overview and Total Revenue
- 11.7.3 In-Cell-Art Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 In-Cell-Art RNA Vaccines Products Offered
- 11.7.5 In-Cell-Art Recent Development
- 11.8 eTheRNA
- 11.8.1 eTheRNA Corporation Information
- 11.8.2 eTheRNA Description, Business Overview and Total Revenue
- 11.8.3 eTheRNA Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 eTheRNA RNA Vaccines Products Offered
- 11.8.5 eTheRNA Recent Development
- 11.9 Ethris
- 11.9.1 Ethris Corporation Information
- 11.9.2 Ethris Description, Business Overview and Total Revenue
- 11.9.3 Ethris Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Ethris RNA Vaccines Products Offered
- 11.9.5 Ethris Recent Development
- 11.10 Tiba Biotechnology
- 11.10.1 Tiba Biotechnology Corporation Information
- 11.10.2 Tiba Biotechnology Description, Business Overview and Total Revenue
- 11.10.3 Tiba Biotechnology Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Tiba Biotechnology RNA Vaccines Products Offered
- 11.10.5 Tiba Biotechnology Recent Development
- 11.1 Moderna Therapeutics
- 11.1.1 Moderna Therapeutics Corporation Information
- 11.1.2 Moderna Therapeutics Description, Business Overview and Total Revenue
- 11.1.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Moderna Therapeutics RNA Vaccines Products Offered
- 11.1.5 Moderna Therapeutics Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 RNA Vaccines Market Estimates and Projections by Region
- 12.1.1 Global RNA Vaccines Sales Forecast by Regions 2021-2026
- 12.1.2 Global RNA Vaccines Revenue Forecast by Regions 2021-2026
- 12.2 North America RNA Vaccines Market Size Forecast (2021-2026)
- 12.2.1 North America: RNA Vaccines Sales Forecast (2021-2026)
- 12.2.2 North America: RNA Vaccines Revenue Forecast (2021-2026)
- 12.2.3 North America: RNA Vaccines Market Size Forecast by Country (2021-2026)
- 12.3 Europe RNA Vaccines Market Size Forecast (2021-2026)
- 12.3.1 Europe: RNA Vaccines Sales Forecast (2021-2026)
- 12.3.2 Europe: RNA Vaccines Revenue Forecast (2021-2026)
- 12.3.3 Europe: RNA Vaccines Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific RNA Vaccines Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: RNA Vaccines Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: RNA Vaccines Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: RNA Vaccines Market Size Forecast by Region (2021-2026)
- 12.5 Latin America RNA Vaccines Market Size Forecast (2021-2026)
- 12.5.1 Latin America: RNA Vaccines Sales Forecast (2021-2026)
- 12.5.2 Latin America: RNA Vaccines Revenue Forecast (2021-2026)
- 12.5.3 Latin America: RNA Vaccines Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa RNA Vaccines Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: RNA Vaccines Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: RNA Vaccines Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: RNA Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key RNA Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 RNA Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on RNA Vaccines. Industry analysis & Market Report on RNA Vaccines is a syndicated market report, published as Global RNA Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of RNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
